v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash $ 887,212 $ 1,038,952
Prepaid insurance 14,597 20,898
Other prepaid expenses 87,943 85,653
Total current assets 989,752 1,145,503
Deferred offering costs 198,826
Total assets 1,188,578 1,145,503
Current liabilities:    
Accounts payable and accrued expenses, including $10,000 and $27,500 to related parties at June 30, 2025 and December 31, 2024, respectively 92,149 83,206
Research and development contract liabilities 256,147 235,078
Accrued offering costs 188,826
Total current liabilities 537,122 318,284
Commitments and contingencies
Stockholders’ equity:    
Preferred Stock, $0.0001 par value; authorized – 10,000,000 shares; issued and outstanding –0 350,000 shares of Series A Convertible Preferred Stock, $10.00 per share stated value, convertible into0 72,917 shares of common stock 3,500,000
Common stock, $0.0001 par value; authorized – 100,000,000 shares; issued and outstanding – 2,756,991 shares and 2,249,290 shares at June 30, 2025 and December 31, 2024, respectively 276 225
Additional paid-in capital 54,204,101 49,394,687
Accumulated deficit (53,552,921) (52,067,693)
Total stockholders’ equity 651,456 827,219
Total liabilities and stockholders’ equity $ 1,188,578 $ 1,145,503